Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Campana (2010)
Minimal residual disease in acute lymphoblastic leukemia.Hematology. American Society of Hematology. Education Program, 2010
L. Silverman, S. Sallan (2002)
Treatment of Childhood Acute Lymphoblastic Leukemia
Iftekhar Naim, S. Datta, Jonathan Rebhahn, J. Cavenaugh, T. Mosmann, Gaurav Sharma (2014)
SWIFT—Scalable Clustering for Automated Identification of Rare Cell Populations in Large, High-Dimensional Flow Cytometry Datasets, Part 1: Algorithm DesignCytometry, 85
A. Bashashati, R. Brinkman (2009)
A Survey of Flow Cytometry Data Analysis MethodsAdvances in Bioinformatics, 2009
D. Campana (2009)
Minimal residual disease in acute lymphoblastic leukemiaSemin Hematol, 46
W. Finn, K. Carter, R. Raich, L. Stoolman, A. Hero (2009)
Analysis of clinical flow cytometric immunophenotyping data by clustering on statistical manifolds: Treating flow cytometry data as high‐dimensional objectsCytometry Part B: Clinical Cytometry, 76B
N. Aghaeepour, R. Nikolic, H. Hoos, R. Brinkman (2011)
Rapid cell population identification in flow cytometry dataCytometry Part A, 79A
J. Frelinger, T. Kepler, Cliburn Chan (2008)
Flow: Statistics, visualization and informatics for flow cytometrySource Code for Biology and Medicine, 3
I Naim, S Datta, J Rebhahn, JS Cavenaugh, TR Mosmann, G. Sharma (2014)
SWIFT-scalable clustering for automated identification of rare cell populations in large, high-dimensional flow cytometry datasets, part 1: algorithm design: SWIFT Flow Cytometry Clustering—Part 1Cytometry A, 85
Kenneth Lo, F. Hahne, R. Brinkman, R. Gottardo (2009)
flowClust: a Bioconductor package for automated gating of flow cytometry dataBMC Bioinformatics, 10
C. Pui, L. Robison, A. Look (2008)
Acute lymphoblastic leukaemiaThe Lancet, 371
M. Schrappe (2012)
Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patient.Hematology. American Society of Hematology. Education Program, 2012
Christopher Bishop (2006)
Pattern Recognition and Machine Learning (Information Science and Statistics)
M. Schrappe (2012)
Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patientHematol Educ Program Am Soc Hematol, 2012
C. Eckert, G. Henze, K. Seeger, N. Hagedorn, G. Mann, R. Panzer-Grümayer, C. Peters, T. Klingebiel, A. Borkhardt, M. Schrappe, A. Schrauder, G. Escherich, L. Sramkova, F. Niggli, J. Hitzler, A. Stackelberg (2013)
Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 21
Y. Qian, Chungwen Wei, F. Lee, John Campbell, Jessica Halliley, Jamie Lee, Jennifer Cai, Y. Kong, E. Sadat, Elizabeth Thomson, P. Dunn, Adam Seegmiller, N. Karandikar, C. Tipton, T. Mosmann, I. Sanz, R. Scheuermann (2010)
Elucidation of seventeen human peripheral blood B‐cell subsets and quantification of the tetanus response using a density‐based method for the automated identification of cell populations in multidimensional flow cytometry dataCytometry Part B: Clinical Cytometry, 78B
Habil Zare, Parisa Shooshtari, Arvind Gupta, R. Brinkman (2010)
Data reduction for spectral clustering to analyze high throughput flow cytometry dataBMC Bioinformatics, 11
G. Walther, Noah Zimmerman, W. Moore, D. Parks, Stephen Meehan, Ilana Belitskaya, Jinhui Pan, L. Herzenberg (2009)
Automatic Clustering of Flow Cytometry Data with Density-Based MergingAdvances in Bioinformatics, 2009
G. Basso, M. Veltroni, M. Valsecchi, M. Dworzak, R. Ratei, D. Silvestri, Alessandra Benetello, B. Buldini, O. Maglia, G. Masera, V. Conter, M. Aricò, A. Biondi, G. Gaipa (2009)
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 31
Andrew Cron, C. Gouttefangeas, J. Frelinger, Lin Lin, Satwinder Singh, C. Britten, M. Welters, S. Burg, M. West, Cliburn Chan (2013)
Hierarchical Modeling for Rare Event Detection and Cell Subset Alignment across Flow Cytometry SamplesPLoS Computational Biology, 9
N. Aghaeepour, Greg Finak, H. Hoos, T. Mosmann, R. Brinkman, R. Gottardo, R. Scheuermann, Michael Biehl (2013)
Critical assessment of automated flow cytometry data analysis techniquesNature Methods, 10
Greg Finak, A. Bashashati, R. Brinkman, R. Gottardo (2009)
Merging Mixture Components for Cell Population Identification in Flow CytometryAdvances in Bioinformatics, 2009
B. Mueller, Thomas Pabst, P. Hauser, G. Gilliland, Donna Neuberg, D. Tenen (2006)
Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemiaBritish Journal of Cancer, 94
E. Costa, C. Pedreira, S. Barrena, Q. Lecrevisse, Juan Flores, Sandra Quijano, J. Almeida, M. Macias, S. Böttcher, J. Dongen, A. Órfão (2010)
Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotypingLeukemia, 24
Minimal residual disease (MRD) is of high prognostic value in risk stratification in childhood acute lymphoblastic leukaemia. Flow cytometry (FCM) was shown to yield reliable results in MRD measurement. However, the interpretation of FCM data relies largely on operator skills and experience. While sample preparation, antibody panels, staining procedures and flow cytometric acquisition can be standardized, easily controlled and be made available worldwide, the availability of experienced operators represents the current bottleneck to a growing number of laboratories to the benefit of an increasing number of patients with leukaemia. Currently, international paediatric studies—throughout Europe, South America, to Australia—aim at stratifying the treatment according to the FCM-MRD methodology. The measurements are still operator-dependent leading to substantial costs regarding training and quality control. This article introduces a new European Union-funded project (AutoFLOW) aiming at the standardization and automation of FCM-MRD analysis by machine-learning technology.
memo - Magazine of European Medical Oncology – Springer Journals
Published: Sep 11, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.